Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 6,6' Dihydroxy 5,5' Bisquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel method for (R)/(S)-6,6'-dihydroxy-5,5'-bisquinoline using CuCl2 oxidation and crystallization resolution, offering high purity and scalable production for pharma intermediates.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.